drugset / Trial / NCT06271928

A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging

NCT06271928 ↗

Phase 0 Unknown 100 enrolled Tongji Hospital
NaSingle-groupOpen-labelTreatment

Summary

Ovarian aging (OA) seriously affects the physical and mental health of women. Nowadays, Chinese herbs have huge appeal and potential in treating OA. We have created a new Chinese herbal combination Yijing Keli, whereas its safety and efficacy still need to be validated. Hence, we will perform a population-based, multicenter study to confirm the safety and efficacy of Yijing Keli in therapy of OA. We aim to provide a solid evidence for TCM in therapy of OA.

Timeline

Start
2021-10-01
Primary completion
2024-01-01
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Yijing Keli Traditional medicine (herbal / TCM) 2 unknown Oral

Indications